Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2003 Feb 1;326(7383):255-6.
doi: 10.1136/bmj.326.7383.255.

Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement

Affiliations

Cholesterol lowering drugs and risk of age related maculopathy: prospective cohort study with cumulative exposure measurement

R van Leeuwen et al. BMJ. .
No abstract available

PubMed Disclaimer

References

    1. Hall NF, Gale CR, Syddall H, Phillips DI, Martyn CN. Risk of macular degeneration in users of statins: cross sectional study. BMJ. 2001;323:375–376. - PMC - PubMed
    1. McCarty CA, Mukesh BN, Guymer RH, Baird PN, Taylor HR. Cholesterol-lowering medications reduce the risk of age-related maculopathy progression. Med J Aust. 2001;175:340. - PubMed
    1. Arnold JJ, Sarks SH. Extracts from “clinical evidence”: age related macular degeneration. BMJ. 2000;321:741–744. - PMC - PubMed
    1. Bird AC, Bressler NM, Bressler SB, Chisholm IH, Coscas G, Davis MD, et al. for the International ARM Epidemiological Study Group. An international classification and grading system for age-related maculopathy and age-related macular degeneration Surv Ophthalmol 199539367–374. - PubMed
    1. In t' Veld BA, Ruitenberg A, Hofman A, Launer LJ, van Duijn CM, Stijnen T, et al. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med. 2001;345:1515–1521. - PubMed

Publication types

Substances